🔥36氪•較早收集於 0m
Neuralink 計劃今年進行首例失明治療植入手術
💡Neuralink 將 BCI 應用從運動控制擴展至感官恢復，有望徹底改變醫療 AI 領域。
⚡ 30-Second TL;DR
有什麼變化
Neuralink 旨在透過 BCI 技術治療失明
為什麼重要
此進展標誌著 BCI 應用向感官恢復的轉變。它突顯了高頻寬神經介面在繞過受損生物系統方面的潛力。
下一步行動
請密切關注 FDA 臨床試驗註冊平台，以獲取 Neuralink 'Blindsight' 裝置審批狀態的最新資訊。
誰應關注：Researchers & Academics
關鍵要點
- •Neuralink 旨在透過 BCI 技術治療失明
- •計劃於 2024 年進行首例視力恢復人體植入手術
- •將 Neuralink 的應用範圍從運動功能恢復進一步擴展
🧠 深度解析
Web-grounded analysis with 32 cited sources.
🔑 增強重點摘要
- •Neuralink's vision restoration project, named "Blindsight," received FDA "Breakthrough Device Designation" in late 2024, which is intended to expedite the regulatory process for promising medical technologies.
- •The Blindsight technology aims to restore vision by directly stimulating neurons in the visual cortex using an implanted microelectrode array, thereby bypassing damaged optic nerves or retinas entirely.
- •Initial visual output from Blindsight is anticipated to be low-resolution, comparable to "Atari graphics," but Elon Musk envisions the technology evolving to offer "superhuman" vision capabilities, such as perceiving infrared or ultraviolet wavelengths.
- •Neuralink has conducted animal testing for Blindsight for over three years, with one monkey reportedly having the visual implant for that duration.
- •Neuralink is collaborating with the University of California, Santa Barbara, on a clinical trial to develop a "Smart Bionic Eye," which pairs brain implants with AI for advanced visual tasks like face recognition, reading, and navigation.
📊 競品分析▸ Show
| Company | Key Features | Data Transfer Rate (bps) | Notes |
|---|---|---|---|
| Neuralink | Invasive, flexible polymer threads (4-6 μm), N1 Implant, R1 surgical robot, Telepathy (motor control), Blindsight (vision) | 10 (for motor control) | Aims for frequent upgrades, consumer-level BCI |
| Paradromics | Invasive, high-bandwidth, platinum iridium electrodes, Connexus BCI, patient-centric design for long-term reliability | 200+ (world-record) | Received FDA IDE approval for Connect One trial, completed first-in-human procedure |
| Synchron | Endovascular (minimally invasive, implanted via blood vessels), Stentrode device, avoids open brain surgery | Not specified | Further along in clinical trials, preparing for large-scale trials, implanted in six patients |
🛠️ 技術深入
- Blindsight operates by implanting a microelectrode array into the visual cortex to directly stimulate neurons, bypassing damaged optic nerves or retinas.
- The system utilizes an external video camera to capture images, processes them into digital signals, and wirelessly transmits these signals to the N1 implant.
- The N1 Implant, also known as "The Link," is a coin-sized, hermetically sealed device (approximately 23mm x 8mm or 23mm x 18mm x 2mm) surgically embedded under the skull, making it cosmetically invisible.
- It contains 1024 electrodes distributed across 64 or 128 flexible polyimide threads, each 4-6 μm wide (thinner than a human hair), which are precisely inserted into the cerebral cortex by the R1 surgical robot.
- Custom Application-Specific Integrated Circuit (ASIC) chips within the implant process neural signals at up to 20 kHz per channel and are capable of compressing neurological data up to 200 times.
- The N1 chip can stimulate any of its electrodes in groups of 64 simultaneously, featuring 16 stimulation engine cores capable of outputting up to 600µA.
- Processed data is transmitted wirelessly via Bluetooth Low Energy to external devices, such as iOS or Android applications, at over 100 Mbps, and the implant is inductively recharged by an N1 Charger.
🔮 前景展望AI analysis grounded in cited sources
Neuralink's Blindsight technology will eventually enable "superhuman" vision capabilities beyond natural human sight.
Elon Musk has stated the long-term goal is to facilitate superhuman vision, such as seeing in infrared or ultraviolet wavelengths, after initially providing low-resolution vision.
The FDA's "Breakthrough Device Designation" for Blindsight will significantly accelerate its path to market and patient access.
This designation is specifically designed to expedite the regulatory process for promising medical technologies treating serious conditions, allowing closer engagement with the FDA and potentially faster clinical trials and approval.
Neuralink's expansion into vision restoration will solidify its position as a leader in generalized BCI applications, moving beyond just motor control.
The company's mission includes restoring autonomy for unmet medical needs and unlocking human potential, with vision restoration being a key step in expanding its BCI capabilities beyond its initial focus on paralysis.
⏳ 時間線
2016
Neuralink founded by Elon Musk and a team of scientists and engineers
2019
Public demonstration of a 'sewing machine-like' implant device reading from a lab rat
2023-05
Received FDA approval for human clinical trials (PRIME Study) for its N1 implant
2024-01-29
First human patient (Noland Arbaugh) successfully implanted with Neuralink's Telepathy device
2024-09
Blindsight implant received FDA 'Breakthrough Device Designation'
2025-07
Joined a clinical trial with the University of California, Santa Barbara, to develop a 'Smart Bionic Eye'
📎 來源 (32)
Factual claims are grounded in the sources below. Forward-looking analysis is AI-generated interpretation.
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
- Google Search Source
📰
AI 週報
閱讀本週精選 AI 大事摘要 →
👉相關動態
AI 策展新聞聚合。所有內容版權歸原始發布者所有。
原始來源： 36氪 ↗